Clinical Trials Directory

Trials / Unknown

UnknownNCT05074745

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Buccal Screening Evaluation Using an RT-PCR Assay and a Rapid ELISA Test Among Symptomatic and Asymptomatic Patients

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Buccal Screening Evaluation Using an RT-PCR Assay and a Rapid ELISA Test Among Symptomatic and Asymptomatic Patients: the CORDAGES Study

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
1,500 (estimated)
Sponsor
Centre Scientifique de Monaco · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The main objective is to expand screening for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by evaluating the diagnostic accuracy of the RT-PCR test (Cobas® Roche, Switzerland) and the ELISA Point of Contact Testing (PORTABLE COVID-19 ANTIGEN LAB® Stark, Italy) on buccal swab compared to the reference test, the RT-PCR test (Cobas® Roche, Switzerland) on nasopharyngeal swab. Secondary objectives * To evaluate the diagnostic accuracy of oral swab RT-PCR and POCT relative to the quantitative amplification (Ct) values of the NP Swab RT-PCR assay. * Analyze RT-PCR amplification cycle thresholds (Ct) and POCT diagnostic accuracy as a function of the presence and timing of symptoms. * Among symptomatic participants, compare clinical presentations between positive and negative participants on the NP swab RT-PCR test. * The RT-PCR test may be imperfectly sensitive, ranging from 71 to 98%3. Using a Bayesian latent class model, the investigators will assess the true accuracy of POCT as it does not require the assumption that any one test or combination of tests is perfect14,15.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTELISA POCT vs RT-PCR3 swabs taken, buccal for RT-PCR and ELISA POCT, nasopharyngeal for RT-PCR

Timeline

Start date
2021-02-18
Primary completion
2021-12-30
Completion
2021-12-30
First posted
2021-10-12
Last updated
2021-10-27

Locations

1 site across 1 country: Monaco

Source: ClinicalTrials.gov record NCT05074745. Inclusion in this directory is not an endorsement.